Forty companies in the pharmaceutical industry presented their joint code of conduct to Minister Bruno Bruins for Medical Care on Friday. This code is meant to be their "moral compass". The Minister immediately called the code inadequate, pointing out that it says nothing about medicine prices - a major point of concern for him, NOS reports.
GroenLinks, SP and PvdA want to take some power away from pharmaceutical companies. Parliamentarians Corinne Ellemeet of GroenLinks, Nine Kooman of SP and Sharon Dijksma of the PvdA presented a list of over 20 proposals on how to do so, including banning pharmaceuticals from sponsoring patient associations, NOS reports.
Over the past five years pharmaceutical companies lost out on about 335 million euros in turnover in the Netherlands because Dutch doctors avoid prescribing expensive diabetes medications, according to research by he institute for responsible medication use IVM
The Dutch Healthcare Inspectorate received a total of 41 reports of patients or their relatives signing non-disclosure contracts with healthcare professionals. Minister Edith Schippers of Public Health called on the public to report such contracts, which are not illegal but considered "highly undesirable"
Dutch pharmaceuticals and oncologists are teaming up in a new experiment to test experimental cancer drugs on patients quickly and safely. Pharmaceuticals will make their cancer drugs available to oncologists, who in exchange will let them know how patients react to the medicines
Two former United Nations consultants were sentenced to imprisonment by a UK court for receiving brides and rigging pharmaceutical contracts in the Democratic Republic of Congo, reported newspaper The Guardian from London’s Southwark crown court. Guido Baker, 41 and Sijbrandus Scheffer, 63, both Dutch nationals, took payments totalling 650,000 pounds from Danish pharmaceutical company, Missionpharma, to help win them lucrative contracts with the UN, investigators allege.
American pharmaceutical firm Pfizer has purchased a minority stake in the Dutch biopharmaceutical AM-Pharma. The American firm has an exclusive option to buy out the whole company after committing an upfront payment of 87.5 million.